Overview of Silibinin anti-tumor effects
MMA Boojar, MMA Boojar, S Golmohammad - Journal of Herbal Medicine, 2020 - Elsevier
Silibinin is a major component of Silymarin mixture (Silybum marianum), which has
traditionally been used to treat a wide range of liver diseases. Recently, Silibinin and its …
traditionally been used to treat a wide range of liver diseases. Recently, Silibinin and its …
Autophagy activated by silibinin contributes to glioma cell death via induction of oxidative stress-mediated BNIP3-dependent nuclear translocation of AIF
C Wang, C He, S Lu, X Wang, L Wang, S Liang… - Cell Death & …, 2020 - nature.com
Induction of lethal autophagy has become a strategy to eliminate glioma cells, but it remains
elusive whether autophagy contributes to cell death via causing mitochondria damage and …
elusive whether autophagy contributes to cell death via causing mitochondria damage and …
Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT)
N Maleki, N Yavari, M Ebrahimi, AF Faiz, RK Ravesh… - Gene, 2022 - Elsevier
Background Silibinin, the principal flavonoid derived from milk thistle seeds, has been
demonstrated to have strong inhibitory effects against human malignancies. The inhibitory …
demonstrated to have strong inhibitory effects against human malignancies. The inhibitory …
Multidrug resistance modulation activity of silybin derivatives and their anti-inflammatory potential
S Dobiasová, K Řehořová, D Kučerová, D Biedermann… - Antioxidants, 2020 - mdpi.com
Silybin is considered to be the main biologically active component of silymarin. Its oxidized
derivative 2, 3-dehydrosilybin typically occurs in silymarin in small, but non-negligible …
derivative 2, 3-dehydrosilybin typically occurs in silymarin in small, but non-negligible …
[PDF][PDF] MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy.
JL Yu, X Gao - … Review for Medical & Pharmacological Sciences, 2020 - europeanreview.org
OBJECTIVE: Ovarian cancer is prone to chemoresistance, leading to poor outcomes in
patients. MicroRNA 1301 plays a regulatory role in multiple tumors. However, whether …
patients. MicroRNA 1301 plays a regulatory role in multiple tumors. However, whether …
Polyphyllin E inhibits proliferation, migration and invasion of ovarian cancer cells by down-regulating the AKT/NF-κB pathway
Y Liu, Y Cao, H Kai, Y Han, M Huang… - Biological and …, 2022 - jstage.jst.go.jp
Ovarian cancer has long been considered the second-highest cancer threat to women's
reproductive system with high mortality. This is ascribed to the absence of highly efficient …
reproductive system with high mortality. This is ascribed to the absence of highly efficient …
Bacteriophages PɸEn-CL and PɸEn-HO can eliminate MDR Enterobacter cloacae and Enterobacter hormaechei isolated from burn wound infections without toxicity …
L Rahimzadeh Torabi, M Doudi… - FEMS Microbiology …, 2021 - academic.oup.com
The prevalence of multidrug-resistant (MDR) strains has caused serious problems in the
treatment of burn infections. MDR Enterobacter cloacae and Enterobacter hormaechei have …
treatment of burn infections. MDR Enterobacter cloacae and Enterobacter hormaechei have …
Exploring the Mechanism of Brucea Javanica against Ovarian Cancer based on Network Pharmacology and the Influence of Luteolin on the PI3K/AKT Pathway
J Zhu, M Han, Y Yang, R Feng, Y Hu… - … chemistry & high …, 2024 - ingentaconnect.com
Background: Ovarian cancer (OC) is a commonly diagnosed female cancer around the
world. The Chinese herbal medicine Brucea Javanica has an anti-cancer effect. However …
world. The Chinese herbal medicine Brucea Javanica has an anti-cancer effect. However …
Research progress on pharmacological effects of silibinin
C Rujing, WU Yunjie, HU Kaili - Shanghai Journal of …, 2022 - shzyyzz.shzyyzz.com
Research progress on pharmacological effects of silibinin is reviewed. Studies have
confirmed that silibinin has various pharmacological activities, such as anti-tumor, liver …
confirmed that silibinin has various pharmacological activities, such as anti-tumor, liver …
cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway
Y Qiu, H Yan, R Zheng, X Chen, Y Wang, Q Yan… - Chemico-Biological …, 2022 - Elsevier
Osteosarcoma (OS) is a group of malignant tumors with high rates of malignancy and
metastasis. OS most commonly affects adolescents and young individuals. However, owing …
metastasis. OS most commonly affects adolescents and young individuals. However, owing …